Loading...

FDA Delays And Rivals Will Hinder Progress But Spark Hope

Published
18 Aug 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-69.7%
7D
-11.5%

Author's Valuation

US$1289.1% undervalued intrinsic discount

AnalystLowTarget Fair Value